Cargando…
Expression of Concern on “The Novel Oral Drug Subetta Exerts an Antidiabetic Effect in the Diabetic Goto-Kakizaki Rat: Comparison with Rosiglitazone”
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6604340/ https://www.ncbi.nlm.nih.gov/pubmed/31317045 http://dx.doi.org/10.1155/2019/2938413 |
Ejemplares similares
-
The Novel Oral Drug Subetta Exerts an Antidiabetic Effect in the Diabetic Goto-Kakizaki Rat: Comparison with Rosiglitazone
por: Bailbé, Danielle, et al.
Publicado: (2013) -
Expression of Concern on “Subetta Treatment Increases Adiponectin Secretion by Mature Human Adipocytes In Vitro”
Publicado: (2019) -
Altered pattern separation in Goto-Kakizaki rats
por: Damphousse, Chelsey C., et al.
Publicado: (2023) -
Expression of Concern: TET1 exerts its tumor suppressor function by regulating autophagy in glioma cells
Publicado: (2020) -
Change in Long-Spacing Collagen in
Descemet's Membrane of Diabetic Goto-Kakizaki Rats
and Its Suppression by Antidiabetic Agents
por: Akimoto, Yoshihiro, et al.
Publicado: (2008)